Shares of Hikma Pharmaceuticals PLC HIK inched down 0.93% to £18.09 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising ...

Analyst Christian Glennie from Stifel Nicolaus reiterated a Buy rating on Hikma Pharmaceuticals (HIK – Research Report) and keeping the ...

Shares of Hikma Pharmaceuticals PLC HIK inched up 0.33% to £18.37 Monday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.65% to ...

Hikma Pharmaceuticals will acquire parts of Danish firm Xellia Pharmaceuticals, a drug company specialising in injectable ...

Investing.com -- Shares of Hikma Pharmaceuticals (LON:HIK) jumped on Thursday after the company raised its full-year guidance ...

London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading. Riad Mishlawi, Hikma’s CEO, said: “I am pleased ...

Hikma Pharmaceuticals' corporate investment arm Hikma Ventures has launched a $30 million digital health fund in Jordan, focusing on therapeutic and diagnostic start-ups. The company's roots are ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Glenmark Specialty SA and Hikma Pharmaceuticals PLC (Hikma). "Across our three businesses, we are driving good demand for our broad product portfolio and recent product launches," Chief Executive ...

But if you try your hand... Hikma Pharmaceuticals in the US joined government officials and non-profit leaders today at a naloxone awareness and training event organized and hosted by Rep.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...